Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.

Saved in:
Bibliographic Details
Title: Anti-FAP CAR-NK cells as a novel targeted therapy against cervical cancer and cancer-associated fibroblasts.
Authors: Polten R; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Kutle I; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Stalp JL; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany., Hachenberg J; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany., Seyda AK; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Neubert L; Institute of Pathology, Hannover Medical School, Hannover, Germany.; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany., Kamp JC; Biomedical Research in Endstage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hannover, Germany.; Department of Respiratory Medicine and Infectious Diseases, Hannover Medical School, Hannover, Germany., von Kaisenberg C; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany., Schaudien D; Department of Pathology and Clinical Chemistry, Fraunhofer Institute for Toxicology and Experimental Medicine, ITEM, Hannover, Germany., Hillemanns P; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany., Klapdor R; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Department of Obstetrics and Gynecology, Hannover Medical School, Hannover, Germany.; Department of Gynecology and Obstetrics, Albertinen Hospital Hamburg, Hamburg, Germany., Morgan M; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany., Schambach A; Institute of Experimental Hematology, Hannover Medical School, Hannover, Germany.; Division of Hematology/Oncology, Boston Children's Hospital, Harvard Medical School, Boston, MA, USA.
Source: Oncoimmunology [Oncoimmunology] 2025 Dec; Vol. 14 (1), pp. 2556714. Date of Electronic Publication: 2025 Sep 17.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:2162-402X
DOI:10.1080/2162402X.2025.2556714